As Researchers Develop Ebola Vaccine, Early Human Clinical Trials Show Promise

October 23, 2014

(Washington Post) – Researchers racing to develop a vaccine that could help halt the Ebola epidemic are getting good news: Early human clinical trials of one leading candidate, involving small groups of volunteers in the United States and Europe, suggest that the vaccine is safe. But the most fraught part of the unprecedented effort lies ahead: Testing the effectiveness of potential vaccines on tens of thousands of people in Ebola-stricken areas of West Africa.